Cowen And Company, LLC Avidity Biosciences, Inc. Transaction History

Cowen And Company, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$22.73 - $40.85 $11.4 Million - $20.4 Million	-500,000 Reduced 8.88%	5,129,103 $210 Million
Q4 2023 Feb 12, 2024	BUY	$4.87 - $9.37 $27.4 Million - $52.7 Million	5,629,103 New	5,629,103 $50.9 Million
Q2 2023 Aug 07, 2023	BUY	$10.62 - $17.34 $11 Million - $18 Million	1,036,137 Added 22.56%	5,629,103 $62.4 Million
Q1 2023 May 09, 2023	BUY	$15.35 - $25.65 $4.68 Million - $7.81 Million	304,600 Added 7.1%	4,592,966 $70.5 Million
Q4 2022 Feb 09, 2023	BUY	$10.06 - $22.66 $5.03 Million - $11.3 Million	500,000 Added 13.2%	4,288,366 $95.2 Million
Q3 2022 Nov 14, 2022	BUY	$15.46 - $23.43 $23.6 Million - $35.7 Million	1,524,216 Added 67.32%	3,788,366 $61.9 Million
Q2 2022 Aug 05, 2022	BUY	$11.18 - $20.5 $25.3 Million - $46.4 Million	2,264,150 New	2,264,150 $32.9 Million

252

107M

224K

161K

Ticker RNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,127,000
Market Cap $1.55B
Description
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Cowen And Company, LLC with notifications on news.